Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119
Graeme Semple(Eurofins (United States)), Robert M. Jones(Arena Pharmaceuticals (United States)), Christopher J. Carroll(St George's, University of London), Karoline Choi(Arena Pharmaceuticals (United States)), Charles Xing(Arena Pharmaceuticals (United States)), Michael Morgan(Arena Pharmaceuticals (United States)), Stuart Bossie(Arena Pharmaceuticals (United States)), David J. Unett(Arena Pharmaceuticals (United States)), William Thomsen, Beatriz Fioravanti(Arena Pharmaceuticals (United States)), Imelda Calderon(Arena Pharmaceuticals (United States)), Yifeng Xiong(Collaborative Innovation Center of Advanced Microstructures), Erin K. Hauser(Arena Pharmaceuticals (United States)), Jane Uy(Arena Pharmaceuticals (United States)), Andrew J. Grottick, James Leonard(Arena Pharmaceuticals (United States)), Albert Ren, Guilherme Rocha Pereira(Pontifícia Universidade Católica de Minas Gerais), Vibha Davé(Arena Pharmaceuticals (United States)), Zhi‐Liang Chu(Arena Pharmaceuticals (United States))
Cited by 142
Related Papers
Bioassay Techniques for Drug Development
|Unknown|2001|799
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
|Endocrinology|2008|382
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury
|Journal of Molecular and Cellular Cardiology|2006|312
Mitochondrial myopathy induces a starvation-like response
|Human Molecular Genetics|2010|306